Literature DB >> 15358608

TNF-alpha induces proliferation or apoptosis in human saphenous vein smooth muscle cells depending on phenotype.

Zhongbiao Wang1, Pulipaka J Rao, Manuel R Castresana, Walter H Newman.   

Abstract

Tumor necrosis factor (TNF)-alpha is implicated in development of restenotic and atherosclerotic vascular lesions, which are pathological processes involving both proliferation and apoptosis of vascular smooth muscle cells (VSMCs). Human VSMCs were recently found to contain heterogeneous subpopulations. We therefore examined whether TNF has different effects on distinct subpopulations of VSMCs. With the use of cloning techniques, two stable subpopulations of VSMCs were isolated from human saphenous vein: spindle- and epithelioid-shaped smooth muscle cells (Sp- and Ep-SMCs, respectively). We found that TNF stimulated growth in Sp-SMCs but had a toxic effect on Ep-SMCs. TNF did not induce apoptosis in Sp-SMCs as determined by nuclear staining and cellular DNA electrophoresis. In contrast, the reduction of viability in Ep-SMCs was associated with induction of apoptosis as characterized by cellular DNA fragmentation and nuclear condensation. Higher levels of the TNF-R1 receptor subtype were detected in membrane preparations from Ep-SMCs than in membranes from Sp-SMCs. Activation of caspase-3 was also selectively induced in Ep-SMCs but not in Sp-SMCs. Cycloheximide, an inhibitor of protein synthesis, enhanced the toxicity of TNF in Ep-SMCs. This effect of cycloheximide was not seen in Sp-SMCs. The data presented here demonstrate for the first time that TNF either promotes growth or induces apoptosis in human VSMCs depending on phenotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358608     DOI: 10.1152/ajpheart.00165.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  15 in total

1.  Tumor necrosis factor-α regulates p27 kip expression and apoptosis in smooth muscle cells of human carotid plaques via forkhead transcription factor O1.

Authors:  Guanghong Jia; Anshu Aggarwal; Steve H Tyndall; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2010-11-11       Impact factor: 3.362

2.  Regulation and characteristics of vascular smooth muscle cell phenotypic diversity.

Authors:  S S M Rensen; P A F M Doevendans; G J J M van Eys
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

3.  TNFα and Reactive Oxygen Signaling in Vascular Smooth Muscle Cells in Hypertension and Atherosclerosis.

Authors:  Fred S Lamb; Hyehun Choi; Michael R Miller; Ryan J Stark
Journal:  Am J Hypertens       Date:  2020-10-21       Impact factor: 2.689

4.  TNF-α response of vascular endothelial and vascular smooth muscle cells involve differential utilization of ASK1 kinase and p73.

Authors:  S Rastogi; W Rizwani; B Joshi; S Kunigal; S P Chellappan
Journal:  Cell Death Differ       Date:  2011-07-08       Impact factor: 15.828

5.  CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration.

Authors:  M Rajesh; P Mukhopadhyay; G Haskó; J W Huffman; K Mackie; P Pacher
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

6.  Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway.

Authors:  Edwige Tellier; Anne Nègre-Salvayre; Beatrice Bocquet; Shigeyoshi Itohara; Yusuf A Hannun; Robert Salvayre; Nathalie Augé
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

7.  Sulforaphane improves dysregulated metabolic profile and inhibits leptin-induced VSMC proliferation: Implications toward suppression of neointima formation after arterial injury in western diet-fed obese mice.

Authors:  Noha M Shawky; Prahalathan Pichavaram; George S G Shehatou; Ghada M Suddek; Nariman M Gameil; John Y Jun; Lakshman Segar
Journal:  J Nutr Biochem       Date:  2016-03-10       Impact factor: 6.048

8.  Induced elastin regeneration by chronically activated smooth muscle cells for targeted aneurysm repair.

Authors:  Chandrasekhar R Kothapalli; Anand Ramamurthi
Journal:  Acta Biomater       Date:  2009-06-06       Impact factor: 8.947

9.  NOD2 agonist promotes the production of inflammatory cytokines in VSMC in synergy with TLR2 and TLR4 agonists.

Authors:  Jinghua Sun; Yanchun Ding
Journal:  ScientificWorldJournal       Date:  2012-09-10

10.  Histological evaluation of age-related variations in saphenous vein grafts used for coronary artery bypass grafting.

Authors:  Bartłomiej Perek; Agnieszka Malińska; Michał Nowicki; Marcin Misterski; Danuta Ostalska-Nowicka; Marek Jemielity
Journal:  Arch Med Sci       Date:  2012-12-19       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.